Cross Country Healthcare, Inc.

NasdaqGS:CCRN Rapporto sulle azioni

Cap. di mercato: US$363.1m

Cross Country Healthcare Performance dei guadagni passati

Il passato criteri di controllo 0/6

Cross Country Healthcare ha registrato una crescita degli utili a un tasso medio annuo di 34.7%, mentre il settore Healthcare ha registrato utili in crescita a un tasso medio annuo di 5.4%. I ricavi sono stati in crescita a un tasso medio annuo di 19.4%.

Informazioni chiave

34.7%

Tasso di crescita degli utili

35.1%

Tasso di crescita dell'EPS

Healthcare Crescita del settore8.5%
Tasso di crescita dei ricavi19.4%
Rendimento del capitale proprio-0.4%
Margine netto-0.1%
Ultimo aggiornamento sui guadagni30 Sep 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Cross Country Healthcare: The Strong Balance Sheet Provides A Sufficient Margin Of Safety

Oct 15

Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Shares Bounce 30% But Its Business Still Trails The Market

Jul 31
Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Shares Bounce 30% But Its Business Still Trails The Market

Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet

Feb 22
Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet

Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Feb 09
Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital

Oct 09
Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital

Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?

Sep 13
Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?

These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well

Aug 19
These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well

Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Jun 26
Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?

Jun 08
At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?

Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?

Apr 28
Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?

Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Mar 15
Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching

Mar 02
Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching

If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity

Jan 20
If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity

Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet

Jan 05
Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet

Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?

Oct 29
Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?

Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital

Oct 14
Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital

Paring My Cross Country Healthcare Gains

Sep 29

Should You Be Adding Cross Country Healthcare (NASDAQ:CCRN) To Your Watchlist Today?

Sep 26
Should You Be Adding Cross Country Healthcare (NASDAQ:CCRN) To Your Watchlist Today?

Cross Country Healthcare to acquire assets of Mint Medical Physician Staffing, LP and Lotus Medical Staffing LLC

Sep 14

Cross Country Healthcare (NASDAQ:CCRN) Has A Pretty Healthy Balance Sheet

Aug 21
Cross Country Healthcare (NASDAQ:CCRN) Has A Pretty Healthy Balance Sheet

Cross Country Healthcare rises postmarket on $100M stock buyback program

Aug 16

Cross Country Healthcare Q2 Non-GAAP EPS, revenue beats, Q3 guidance provided

Aug 03

Ripartizione dei ricavi e delle spese

Come Cross Country Healthcare guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

NasdaqGS:CCRN Ricavi, spese e utili (USD Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Sep 241,448-22710
30 Jun 241,57582870
31 Mar 241,776462900
31 Dec 232,020733150
30 Sep 232,2341023280
30 Jun 232,4281243370
31 Mar 232,6411563440
31 Dec 222,8071883350
30 Sep 222,8192273180
30 Jun 222,5582162910
31 Mar 222,1361752520
31 Dec 211,6771322200
30 Sep 211,252591970
30 Jun 211,071341850
31 Mar 2195691770
31 Dec 20836-131770
30 Sep 20836-191770
30 Jun 20851-211810
31 Mar 20837-581840
31 Dec 19822-581840
30 Sep 19808-761840
30 Jun 19800-741840
31 Mar 19801-201830
31 Dec 18816-171820
30 Sep 18835311830
30 Jun 18863381870
31 Mar 18868411880
31 Dec 17865381890
30 Sep 1786821890
30 Jun 1785491870
31 Mar 17845-131850
31 Dec 1683481800
30 Sep 16804101740
30 Jun 1678511680
31 Mar 16778211640
31 Dec 1576741620
30 Sep 15762-101640
30 Jun 15756-221650
31 Mar 15686-281530
31 Dec 14618-321420
30 Sep 14539-641270
30 Jun 14458-551120
31 Mar 14446-541100
31 Dec 13438-541070

Guadagni di qualità: CCRN al momento non è redditizia.

Margine di profitto in crescita: CCRN al momento non è redditizia.


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: CCRN non è redditizia, ma ha ridotto le perdite negli ultimi 5 anni a un tasso pari a 34.7% all'anno.

Accelerare la crescita: Impossibile confrontare la crescita degli utili di CCRN nell'ultimo anno con la sua media quinquennale poiché al momento non è redditizia

Guadagni vs Settore: CCRN non è redditizia, il che rende difficile confrontare la crescita dei suoi utili dell'anno passato con il settore Healthcare ( 10.2% ).


Rendimento del capitale proprio

ROE elevato: CCRN ha un Return on Equity negativo ( -0.42% ), in quanto al momento non è redditizio.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate